In the context of dramatically increasing food allergy incidence and a breakthrough approval in the field, the Next Generation Food Allergy Drug Development Summit will unite large pharma and innovative biotechs to overcome the unique drug development challenges involved in turning promising food allergy biologics into clinical and commercial realities.

Join us to investigate the latest technological innovations, benchmark against your peers, build global connections and streamline your drug development pipelines for food allergy, with insights being shared from a range of companies and institutions including Aimmune, Camallergy, Allergy Therapeutics, Intrommune, Vedanta Biosciences and University of North Carolina.

Access the official event guide to learn more.

Industry-Leading Speakers Include:

Kari Brown

Senior Medical Director


Matthew Heath

Principal Scientist, Innovation & Product Development

Allergy Therapeutics

Edwin Kim

Associate Professor of Medicine & Pediatrics

University of North Carolina School of Medicine

Sophie Nutten

Science Lead, Allergy


Abhit Singh

VP, Medical Affairs


Mohamed Shamji

Reader in Immunology & Allergy

Imperial College London

Poul Sørensen

Co-Founder & CSO

Allero Therapeutics

Rose Szabady

Director, Immunology

Vedanta Biosciences

Thomas Casale

Chief Medical Advisor for Operations/Professor, Medicine and Pediatrics

FARE/University of South Florida, Tampa

Mimi Tang

Head of Allergy Immunology Research Group

Murdoch Children’s Research Institute and The Royal Children’s Hospital Melbourne

Proud to Partner With: